Future pharmaceutical reform ready for final EU Parliament vote

Innovative medicines regulations require that products be more environmentally friendly in the future and cap the data protection period.
Photo: Yves Herman
Photo: Yves Herman

There is a consensus among EU parliamentarians for a comprehensive pharmaceutical reform, which is now facing its crucial vote in the EU Parliament, aimed at promoting innovation and increasing the security of supply and availability of medicines, especially within new types of medicines and antibiotics, the EU Parliament writes in a statement.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading